Nippon Shinyaku Co., Ltd. (OTCMKTS:NPNKF – Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 64,338 shares, a decline of 84.4% from the November 30th total of 413,213 shares. Based on an average daily trading volume, of 164 shares, the days-to-cover ratio is presently 392.3 days. Based on an average daily trading volume, of 164 shares, the days-to-cover ratio is presently 392.3 days.
Nippon Shinyaku Stock Performance
Shares of NPNKF stock remained flat at $37.75 on Thursday. The company has a 50-day moving average of $26.27 and a 200 day moving average of $25.59. Nippon Shinyaku has a 1 year low of $21.00 and a 1 year high of $38.01.
Nippon Shinyaku Company Profile
Nippon Shinyaku Co, Ltd. operates as a research-driven pharmaceutical company headquartered in Kyoto, Japan. It specializes in the discovery, development, manufacture and marketing of therapeutic drugs across multiple therapeutic areas, including urology, hematology, oncology and internal medicine. The company’s business model integrates in-house research capabilities with strategic collaborations to bring novel small-molecule and biologic products to market.
Established in 1909 by entrepreneur Yorisuke Tsuji, Nippon Shinyaku has evolved from a domestic manufacturer into a global healthcare enterprise.
Read More
- Five stocks we like better than Nippon Shinyaku
- Do not delete, read immediately
- Can Any Expenses Be Deducted From Capital Gains Tax?
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Forget AI, This Will Be the Next Big Tech Breakthrough
Receive News & Ratings for Nippon Shinyaku Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nippon Shinyaku and related companies with MarketBeat.com's FREE daily email newsletter.
